Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Stancliff

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection preventionFrederick L Altice, Lynn E Sullivan, Duncan Smith-Rohrberg, et al.
Substance Use & Misuse|June 24, 2008
Evaluation of a naloxone distribution and administration program in New York CityTinka Markham Piper, Sharon Stancliff, Sasha Rudenstine, et al.
Harm Reduction Journal|January 27, 2007
Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York CityTinka Markham Piper, Sasha Rudenstine, Sharon Stancliff, et al.
Clinical Therapeutics|September 26, 2025
Pharmacists' Knowledge and Perceptions of Buprenorphine at New York State Pharmacies: Identifying the Extent of Pharmacy-Level Barriers to Access BuprenorphineMariana Buziashvili, Katarina Colón, Elizabeth M Boos, et al.
Harm Reduction Journal|September 19, 2022
Naloxone administration by law enforcement officers in New York State (2015-2020)Elham Pourtaher, Emily R Payne, Nicole Fera, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection preventionFrederick L Altice, Lynn E Sullivan, Duncan Smith-Rohrberg, et al.
Substance Use & Misuse|June 24, 2008
Evaluation of a naloxone distribution and administration program in New York CityTinka Markham Piper, Sharon Stancliff, Sasha Rudenstine, et al.
Harm Reduction Journal|January 27, 2007
Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York CityTinka Markham Piper, Sasha Rudenstine, Sharon Stancliff, et al.
Clinical Therapeutics|September 26, 2025
Pharmacists' Knowledge and Perceptions of Buprenorphine at New York State Pharmacies: Identifying the Extent of Pharmacy-Level Barriers to Access BuprenorphineMariana Buziashvili, Katarina Colón, Elizabeth M Boos, et al.
Harm Reduction Journal|September 19, 2022
Naloxone administration by law enforcement officers in New York State (2015-2020)Elham Pourtaher, Emily R Payne, Nicole Fera, et al.
Pageof 3